Evidence map›Paper›PMID 41354841›Full record

ArticleNature communications2025

Carboxymethylcytosine is a natural base modification and a handle for bacteriophage DNA hypermodification.

Qiaoyu Yang, Lin Zhang, Yantao Liang, Haoyu Ma, Lifu Song, Lin Luo, Jason Tan, Yiling Hu, Kailiang Ma, Yiwei Chen and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Qiaoyu Yang *New Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Lin Zhang *School of Chemistry and Chemical Engineering, and Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0002-3076-6993
Yantao Liang *College of Marine Life Sciences, Ocean University of China, Qingdao, China.ORCID http://orcid.org/0000-0002-2477-8197
Haoyu MaiHuman Institute and School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Lifu SongTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Lin LuoCollege of Marine Life Sciences, Ocean University of China, Qingdao, China.
Jason TanSingapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, Nanos, Singapore, Singapore.
Yiling HuNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Kailiang MaNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Yiwei ChenNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Yang TongNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Chuyuan ZhangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Suwen ZhaoiHuman Institute and School of Life Science and Technology, ShanghaiTech University, Shanghai, China. zhaosw@shanghaitech.edu.cn.ORCID http://orcid.org/0000-0001-5609-434X
Min WangCollege of Marine Life Sciences, Ocean University of China, Qingdao, China. mingwang@ouc.edu.cn.ORCID http://orcid.org/0000-0002-2357-589X
Liang ZhangSchool of Chemistry and Chemical Engineering, and Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai, China. liangzhang2014@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-7672-1168
Yifeng WeiSingapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, Nanos, Singapore, Singapore. weiyf@a-star.edu.sg.ORCID http://orcid.org/0000-0001-9124-0381
Yan ZhangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. yan.zhang@tju.edu.cn.ORCID http://orcid.org/0000-0003-2031-0631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages possess a wide array of DNA modifications, with many acting as molecular camouflage to evade host immune defenses. Sequence databases contain numerous bacteriophage enzymes of unknown function, with some potentially involved in yet to be identified DNA modifications. Here we report the discovery of a DNA cytosine C5-carboxymethyltransferase (CmoX) in Synechococcus phage S-B43, which catalyzes the formation of a 5-carboxymethylcytosine (5cxmC), previously reported as an unnatural DNA modification formed by an engineered cytosine methyltransferase. The carboxy-S-adenosyl-L-methionine (Cx-SAM) cofactor required by CmoX is provided by a phage-encoded Cx-SAM synthase (CmoA), a homolog of the bacterial CmoA involved in tRNA modification. A crystal structure of CmoX in complex with Cx-SAM revealed the basis for its substrate selectivity, involving a key Arg residue interacting with the substrate carboxy group. In addition, we characterize a phage-encoded ATP-dependent amide ligase, CmoY that catalyzes the formation of 5cxmC-glycine amide. CmoA is present in many bacteriophage genomes, typically alongside CmoX and homologs of CmoY, suggesting that 5cxmC modification is a widespread naturally occurring DNA modification serving as a handle for further hypermodifications in bacteriophages. Our study underscores the ability of bacteriophages to repurpose RNA modification enzymes to expand their repertoire of DNA modifications.

Indexed as

BacteriophagesCytosineDNA, ViralCrystallography, X-RayDNA MethylationModels, MolecularS-AdenosylmethionineSubstrate SpecificitySynechococcusViral ProteinsCytosineDNA, ViralS-AdenosylmethionineViral Proteins

Identifiers

PMID41354841
PMCPMC12783734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.